NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 82 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 20 | -48.7% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 39 | -99.8% | 0.00% | – |
| Q3 2021 | $128,000 | -21.5% | 17,713 | -0.4% | 0.00% | – |
| Q2 2021 | $163,000 | -24.5% | 17,777 | +0.9% | 0.00% | – |
| Q1 2021 | $216,000 | -63.6% | 17,612 | -58.2% | 0.00% | – |
| Q4 2020 | $594,000 | +239.4% | 42,158 | +188.8% | 0.00% | – |
| Q3 2020 | $175,000 | – | 14,596 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,862,931 | $46,355,000 | 3.30% |
| Opaleye Management Inc. | 1,386,300 | $16,636,000 | 3.25% |
| Fairmount Funds Management LLC | 372,748 | $4,473,000 | 1.90% |
| Redmile Group, LLC | 4,172,686 | $50,072,000 | 0.92% |
| Boxer Capital, LLC | 1,501,058 | $18,013,000 | 0.62% |
| Prosight Management, LP | 66,376 | $797,000 | 0.38% |
| HighVista Strategies LLC | 39,234 | $471,000 | 0.34% |
| Baker Brothers Advisors | 3,821,740 | $45,861,000 | 0.18% |
| Granahan Investment Management | 296,511 | $3,558,000 | 0.12% |
| Sio Capital Management, LLC | 38,312 | $460,000 | 0.09% |